Clinical trial
Ondansetron for Bipolar Disorder and Alcohol Use Disorders
NCT02082678 is registered in ClinicalTrials.gov with University of Texas Southwestern Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ondansetron for Bipolar Disorder and Alcohol Use Disorders
- Lead sponsor
- University of Texas Southwestern Medical Center
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- February 28, 2014
- Completion date
- May 31, 2018
- Enrollment
- 70 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
alcohol use disorder, bipolar disorder, dual diagnosis